RESYNCHRONIZING THERAPY LONG-TERM RESULTS IN INFANCY TREATED FOR SECONDARY (ARRHYTHMOGENIC) DILATION CARDIOMYOPATHY AFTER SURGICAL INTERVENTION
Abstract
Secondary dilation (arrhythmogenic) cardiomyopathy in children after artificial pacemaker implantation occurs rather rare. Criteria for implantation are typical: expressed disorders of systemic ventricle function (lowering EF < 35% in dynamics) and prolongation of QRS interval more 120 ms. Heart transplantation is the only alternative. We present 2 cases with successful application of cardioresynchronizer for critical lowering EF at a time of AP implantation. We consider this method will assist in overcoming critical decompensated heart insufficiency and it is a good alternative to the only reliable approach in these children-heart transplantation. The age of patients is not a constraint factor.
About the Authors
M. L. Kandinsky
Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
G. A. Efimochkin
Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
O. V. Klycheva
Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
O. V. Kokhtacheva
Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
M. V. Latkin
State Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital of Krasnodar Region Public Health Ministry
Russian Federation
Russian Federation
M. V. Boriskov
Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
References
1. Resynchronization Therapy in Pediatric and Congenital Heart Disease Patients. An International MultiCenter Study. Journal of the American College of Cardiology Vol. 46, No. 12, 2005 Anne M. Dubin, MD, FACC,* Jan Janousek, MD, Edward Rhee, MD, FACC и соавторы.
2. Cardiac resynchronization therapy for pediatric heart failure. Heart Rhythm, Vol. 5, No 10, October 2008 Pag. 1476 - 78. Jennifer N. Avari, MD, Edward K. Rhee, MD.
3. Cleland J.G., Abdellah A.T., Khaleva O., et al. Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure. Eur J Heart Fail 2007; 9: 1070 -1073.
4. Cecchin F., Frangini P.A., Brown D.W., Fynn-Thompson F., Alexander M.E., Triedman J.K., Gauvreau K., Walsh E.P., Berul C.I. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol 2009; 20: 58 - 65.
5. Cardiac resynchronization therapy in patients with congenital heart disease. Jean-Benoit Thamboa, b,c, Pierre Dos Santosb, c, Pierre Bordacharb, c. Archives of Cardiovascular Disease (2011) 104, 410 - 416.
6. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. Kenneth A. Ellenbogen, Bruce L. Wilkoff, G. Neal Kay, Chu Pak Lau, Angelo Auricchio. Elsevier Health Sciences, 30 мар. 2016. -1300p. - P.692 - 708.
Review
For citations:
Kandinsky M.L., Efimochkin G.A., Klycheva O.V., Kokhtacheva O.V., Latkin M.V., Boriskov M.V. RESYNCHRONIZING THERAPY LONG-TERM RESULTS IN INFANCY TREATED FOR SECONDARY (ARRHYTHMOGENIC) DILATION CARDIOMYOPATHY AFTER SURGICAL INTERVENTION. Innovative Medicine of Kuban. 2017;5(1):37-41. (In Russ.)
Views:
302
Email this article 
